For example, the FDA said about 20% of the bioreactor ... Sanofi (NYSE: SNY) acquired the Framingham facility when it bought Massachusetts-based Genzyme in a deal worth over $20 billion in 2011.
Massachusetts. On Jan. 15, 2025, a warning letter was sent to Sanofi stating that FDA inspectors found irregularities with the facility's bioreactor, the vessel used to grow organisms and cells.
Although the product had previously been approved in Europe, GTC Biotherapeutics of Framingham, Massachusetts ... follows closely on the heels of the FDA final guidance issued a month earlier ...
FRAMINGHAM — City officials announced the ... The MBTA Communities Act requires 177 communities in eastern Massachusetts to designate at least one zoning district that allows for multifamily ...
Sanofi already has a biologics hub at the plant in Framingham, Massachusetts, which has been a global hub for the company for more than 30 years. The plant is important to Sanofi as its pipeline ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results